TrialClinical nuclear medicine2017

89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.

Gary A Ulaner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.